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Cellular immunity in pertussis
Considerable advances have been made recently in our understanding of the pathogenesis and the immunological mechanisms involved in the prevention and control of infection by Bordetella pertussis. Traditionally, research on protection has focused on the role of humoral immunity and several reports have shown that passive transfer of antibodies against several putative protective antigens, including pertussis toxin (PT), filamentous haemagglutinin (FHA) and pertactin, can confer a level of protection in mice against intracerebral or respiratory challenge? However, the results of a clinical trial in Sweden,2 as well as a number of active immunisation experiments in mice and rabbit^^-^ have also failed to find a correlation between serum antibody levels to B. pertussis components and protection. While circulating antibodies do play a role, both in toxin neutralisation and in preventing bacterial attachment following transudation into the lungs, evidence is now emerging that cell-mediated immunity may also be required for protection against B. pertussis.
Recent reports have suggested that B. pertussis is not exclusively an extracellular pathogen. It has been shown that B. pertussis can be taken up and survive within mammalian cells including macrophages in vitro.6t Furthermore, organisms have been found within alveolar macrophages from the lungs of HIVinfected individuals. These findings suggest that cellmediated immunity would be required to control an intracellular state of B. pertussis, which could escape immune defences mediated by antibody.
The earliest studies on the cellular immune response to B. pertussis described the induction and specificity of proliferative CD4+ T cells in human subjects and mice after immunisation or infection.'-13 De Magistris and colleagues'? demonstrated T-cell responses to PT, FHA and pertactin in adults who had suffered from pertussis in childhood. CD4+ T-cell clones specific for FHA and pertactin were established by re-stimulation of peripheral blood mononuclear cells (PBMC) in vitro with killed whole bacteria, whereas PT-specific clones were established only when PT was used for restimulation in ~i t r o .~ These findings suggested that PT may not be a major target for T cells from previously infected individuals or that formaldehyde treatment of the bacteria affected the processing or T-cell recognition of epitopes on PT. Evidence for the latter possibility was provided from observations in our laboratories that T cells from mice convalescing from B. pertussis infection failed to respond to aldehydetreated PT (PTd), but did respond to a sub-mitogenic dose of active PT and to a mutant PT molecule devoid of mitogenicity.12 This study showed that FHA, pertactin and agglutinogens 2 and 3 were also recognised by T cells from convalescent mice.12
A number of research groups have used synthetic peptides to identify T-cell epitopes on the S-1, S-2, S-3 and S-4 subunits of PT.g910713.'4 Although the definition of T cells specific for B. pertussis antigens provides circumstantial evidence for the role of cellmediated immunity in protection against B. pertussis, a direct demonstration of the involvement of T cells has been provided only recently through experiments with the murine respiratory infection m0de1.l~ It was shown that following aerosol challenge nude mice, which are deficient in T cells, failed to clear the bacteria and developed a chronic infection. In contrast, normal naive mice cleared the infection within 35 days of challenge. Adoptive transfer of splenic T cells or purified CD4+ T cells, from mice rendered immune by previous infection, into nude or immunosuppressed (sublethally irradiated) recipient mice resulted in elimination of bacteria within 15-20 days of challenge. Furthermore, there were no detectable serum antibodies to B. pertussis antigens in the recipients at the time of bacterial clearance. These findings suggest that cell-mediated immunity plays an important role in the elimination of a primary infection and in protection against subsequent challenge.
Our study,15 as well as that of Petersen et aZ.,l6 suggested that spleen cells from convalescent mice produced high levels of IL-2, IFN-7 and TNF, but no detectable IL-4 and very low levels of IL-5. This pattern of lymphokine secretion is characteristic of Thl subpopulations of CD4+ T cells that are predominantly involved in inflammatory, DTH and cytotoxic functions. Furthermore, Peppoloni et a1.l' showed that B. pertussis-specific CD4+ T-cell clones from previously infected human subjects secrete IL-2 and IFN-y, but little or no IL-4, and displayed cytotoxic activity against target cells pulsed with killed bacteria. The studies in mice also showed that proliferative T cell responses to B. pertussis antigens could be detected within 2 weeks of infection, whereas anti-B. pertussis antibodies had not reached significant levels at the time of bacterial elimination. These observations suggest a direct role for Thl cells in immunity to B. pertussis.
In recent investigations, undertaken at NIBSC, we have also found that immunisation of mice with a whole-cell pertussis vaccine induces a good Thl response and moderate antibody 1evels.l' In contrast, immunisation with an acellular vaccine comprising PTd FHA and pertactin generated a strong antibody response and T cells that secreted IL-5, but not IL-2 or IFN-y; a lymphokine profile characteristic of Th2 cells, which are considered to be the true helper T cells for stimulating antibody response to foreign antigen. The slower bacterial clearance after respiratory challenge of mice immunised with the acellular vaccine, when compared with mice immunised with the wholecell vaccine or convalescent mice, is considered to reflect the failure of the acellular vaccine to induce B. pertussis-specific Th 1 cells. However, the pattern of bacterial clearance in mice immunised with the acellular vaccine is compatible with the role of antibody, stimulated by Th2 cells, in reducing the numbers of organisms in the lungs early in the course of the infection.
In conclusion, the findings from murine models, as well as circumstantial evidence from studies in man, suggest that, while antibody plays a role in preventing colonisation and combating toxin-mediated disease, complete bacterial clearance requires cellular immune responses mediated by Thl cells. Thl cells could operate to stimulate the recruitment, phagocytic function and intracellular killing of B. pertussis by macrophages. Th 1 cells could also function through their cytotoxic activity against the infected macrophages and thereby allow subsequent destruction of the intracellular reservoirs of the bacteria. Whatever the mechanism, it is now established that T cells are induced by immunisation and infection, and that these T cells play a vital role, not only in regulation of the antibody response, but in direct cell-mediated immunity against B. pertussis.
